Navigation Links
The In View series hosted by Larry King Announces plans for a series on Autoimmune Diseases
Date:2/8/2013

Boca Raton, FL (PRWEB) February 08, 2013

The producers of the In View TV series, an educational TV series hosted by Larry King, have announced plans to focus on autoimmune diseases and the push to cure them in an upcoming series. These diseases, which have no cure and often have nebulous causes, afflict tens of millions of Americans, affecting their health and quality of life. Diseases that come under this classification include type-I diabetes, multiple sclerosis and rheumatoid arthritis. The In View Larry King show, which runs on cable outlets across the country, will inform TV audiences about some of the many autoimmune diseases, in which the body’s immune system attacks and destroys healthy tissues and cells, as well as efforts to cure these diseases and develop better treatments for them. The Larry King TV show will spotlight researchers as well as companies across the country working to develop cures and treatments.

In November, researchers at the National Institute of Biomedical Imaging and Bioengineering announced a possible breakthrough in the treatment of autoimmune diseases. The institute’s approach involved re-educating the body’s T-cells to not attack healthy tissue. This series of the In View with Larry King show (http://www.inviewseries.com) will look at advances such as this and more, giving rare attention to diseases and patients that often get overlooked. The In View TV series (855-446-8439) will showcase organizations and companies that have made progress in the fight against various autoimmune disorders and diseases.

The Larry King In View show (561-544-7965) offers enlightening episodes and series on many important and timely subjects throughout American culture. It features veteran television personality Larry King, the long-time host of “Larry King Live” on CNN.

Read the full story at http://www.prweb.com/releases/in-view-with-larry-king/autoimmune-diseases/prweb10413646.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
2. DuPont Pioneer Launches Next Generation T Series Soybeans
3. Management Matters Series Starts with “Lab Budgeting 101”
4. QSI Announces RS Series of Deep Cooled CCD Cameras
5. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
6. Rudy Mazzocchi Prepares to Release the Second Thriller in The EQUITY Series Trilogy, entitled EQUITY of FEAR
7. The Veterinary Bioscience Institute Announces an Amazing Series of 41 Webinars for 2013
8. BioTechniques Announces the Publication of 'Transfection' – The First Issue of a New, Digital-Only Spotlight Series
9. Avelas Biosciences Closes $7.65 Million Series A, Advances Real-Time Tumor Visualization Technology Toward Development
10. Rhythm Expands Series B Financing to $33 Million; Adds Pfizer Ventures as an Investor
11. Advanced Cell Diagnostics Completes $12 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)...  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a clinical ... to commercialize innovative therapeutics for patients with cancer, ... approved for trading on the OTCQX U.S. market. ... effective today, under the ticker symbol "HPPI." ... must meet high financial standards, follow best practice ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. presented ... expansion clinical trial for its lead drug candidate, AC0010, at the World Conference ... was to determine the safety, antitumor activity, and recommended phase II dosage of ...
(Date:12/7/2016)... 2016 /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces ... at the Company,s Annual and Special Meeting. ... place on Thursday, December 15, 2016 at Mount ... EC1040), 4825 Mount Royal Gate SW, Calgary, Alberta ... meeting and management information circular, containing the matters to be ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... type (Fingerprint, Voice), Future Technology (Iris Recognition System), ... Region - Global Forecast to 2021", published by ... 442.7 Million in 2016, and is projected to ... a CAGR of 14.06%.      (Logo: ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH llc ... partnership initiative targeting national brands, industry thought-leaders and ... their respective audiences for taking steps to live ... inception in 2012, higi has built the largest ... over 38 million people who have conducted over ...
(Date:11/29/2016)... France , November 29, 2016 Nearly one ... Continue Reading ... ... is part of an efficient Identity Management. (PRNewsFoto/DERMALOG Identification Systems) ... DERMALOG is Germany's largest Multi-Biometric supplier: ...
Breaking Biology News(10 mins):